Opdivo is being counterfeited: what to watch out for

He National Institute for Food and Drug Surveillance (Invima) Warns about fraudulent marketing of the product Opdico (Nimolumab) Solution 100
mg/10mlwhich are being falsified, since it would not have the health registry of the entity.

This fake product corresponds to the lot EEES3542 with an expiration date in the month of December 2022which was not by the manufacturing company in its inventory system.

(This will be the Chinese company that will produce vaccines in Bogotá).

(Transparency for Colombia sees risks in health reform).

The proviso is made that the lot ACC4096 with an expiration date of October 2023, it is codified exclusively for the Mexican market; However, this product, as explained by Invima, this product has detachable dark gray covers, as well as small size instructions. This while variable lot data and vial expiration dates are close to the label line.

(Labor reform would hit the drugstore sector).

From the Invima it is recommended for citizens:

1. Refrain from purchasing Opdivo (Nimolumab) 100mg/10ml solution with lot numbers EEES3542 and ACC4096 with the characteristics described.

2. Do not buy medicines or daily supplements without current health registration, as these products may contain ingredients that may put the consumer’s health at risk.

3. If you are consuming the product, immediately suspend its use, inform Invima or the health authorities where said product is marketed. If an adverse health effect has been registered, report it through this link or by email [email protected].

4. Immediately inform the territorial health entity or entities in the event of knowledge of places where this product is distributed or marketed.

BRIEFCASE